ISL
CDLX icon

Ingalls & Snyder LLC’s Cardlytics CDLX Stock Holding History

Ingalls & Snyder LLC’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,072
Closed -$20K – 470
2025
Q1 		$20K Sell
1,072
-333
-24% -$9.51K ﹤0.01% 454
2024
Q4 		$52K Sell
1,405
-1,160
-45% -$44.4K ﹤0.01% 432
2024
Q3 		$82K Sell
2,565
-681
-21% -$37.8K ﹤0.01% 438
2024
Q2 		$267K Buy
3,246
+1,670
+106% +$181K 0.01% 355
2024
Q1 		$228K Sell
1,576
-49
-3% -$4.14K 0.01% 393
2023
Q4 		$150K Sell
1,625
-58
-3% -$5.9K 0.01% 409
2023
Q3 		$278K Sell
1,683
-5
-0.3% -$650 0.01% 353
2023
Q2 		$107K Sell
1,688
-13
-0.8% -$787 0.01% 412
2023
Q1 		$58K Sell
1,701
-375
-18% -$19.6K ﹤0.01% 417
2022
Q4 		$120K Sell
2,076
-122
-6% -$7.54K 0.01% 412
2022
Q3 		$207K Sell
2,198
-146
-6% -$20.8K 0.01% 390
2022
Q2 		$523K Sell
2,344
-11
-0.5% -$3.68K 0.03% 275
2022
Q1 		$1.29M Buy
2,355
+1,617
+219% +$977K 0.06% 191
2021
Q4 		$488K Buy
738
+147
+25% +$112K 0.02% 311
2021
Q3 		$496K Buy
+591
New +$600K 0.02% 310

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Ingalls & Snyder LLC's CDLX Position: Q2 2025 in Review

Ingalls & Snyder LLC sold out of Cardlytics (CDLX) in Q2 2025, closing a stake of 1,072 shares — an estimated $20K sold.

Ingalls & Snyder LLC first reported a position in CDLX in Q3 2021 and held it in 15 quarters. The position peaked at $1.29M in Q1 2022. 89 funds tracked by Wall St. Rank hold CDLX as of Q2 2025.

  • Ingalls & Snyder LLC reported no remaining Cardlytics position as of Q2 2025 after selling out during the quarter.
  • Ingalls & Snyder LLC sold 1,072 Cardlytics shares in Q2 2025, an estimated $20K.
  • Ingalls & Snyder LLC first reported a position in Cardlytics in Q3 2021 and held it in 15 quarters.
  • Ingalls & Snyder LLC's Cardlytics position peaked at $1.29M in Q1 2022.
  • 89 funds tracked by Wall St. Rank held Cardlytics as of Q2 2025.

Based on Ingalls & Snyder LLC's 13F filing for Q2 2025, filed 31 Jul 2025.